| Title | Author(s) | Year | View Count |
 | Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population | Phua, KB; Lim, FS; Lau, YL; Nelson, EAS; Huang, LM; Quak, SH; Lee, BW; Doorn, LJV; Teoh, YL; Tang, H; Suryakiran, PV; Smolenov, IV; Bock, HL; Han, HH | 2012 | 43 |
 | Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: Immunogenicity and safety in healthy Chinese women from Hong Kong | Ngan, HYS; Cheung, ANY; Tam, KF; Chan, KKL; Tang, HW; Bi, D; Descamps, D; Bock, HL | 2010 | 641 |
| Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study | Phua, KB; Lim, FS; Lau, YL; Nelson, EAS; Huang, LM; Quak, SH; Lee, BW; Teoh, YL; Tang, H; Boudville, I; Oostvogels, LC; Suryakiran, PV; Smolenov, IV; Han, HH; Bock, HL | 2009 | 43 |
 | Immunogenicity and safety of cervarizTM in healthy women in Hong Kong | Ngan, HYS; Cheung, ANY; Tam, KF; Chan, KKL; Tang, H; Bi, D; Descamps, D; Bock, HL | 2008 | 96 |
|
